Individual Patient Data Analysis of Randomized Clinical Trials: Impact of Black Race on Castration-resistant Prostate Cancer Outcomes
- 1 December 2016
- journal article
- research article
- Published by Elsevier BV in European Urology Focus
- Vol. 2 (5), 532-539
- https://doi.org/10.1016/j.euf.2016.03.010
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Disparities in Castration-Resistant Prostate Cancer TrialsJournal of Clinical Oncology, 2015
- Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trialThe Lancet Oncology, 2015
- Randomized, Placebo-Controlled, Phase III Trial of Sunitinib Plus Prednisone Versus Prednisone Alone in Progressive, Metastatic, Castration-Resistant Prostate CancerJournal of Clinical Oncology, 2014
- Cancer statistics, 2014CA: A Cancer Journal for Clinicians, 2014
- Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trialThe Lancet Oncology, 2013
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trialThe Lancet, 2010
- Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate CancerClinical Cancer Research, 2010
- Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the WorldJournal of Clinical Oncology, 2006
- Social disparities and prostate cancer: mapping the gaps in our knowledgeCancer Causes & Control, 2005
- Racial and Ethnic Differences in Advanced-Stage Prostate Cancer: the Prostate Cancer Outcomes StudyJNCI Journal of the National Cancer Institute, 2001